Pro Share Advisors LLC Tg Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 29,004 shares of TGTX stock, worth $856,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,004
Previous 18,575 56.15%
Holding current value
$856,778
Previous $330,000 105.45%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$17.21 - $25.28 $179,483 - $263,645
10,429 Added 56.15%
29,004 $678,000
Q2 2024

Aug 13, 2024
SELL
$13.32 - $19.19 $84,435 - $121,645
-6,339 Reduced 25.44%
18,575 $330,000
Q1 2024

May 08, 2024
BUY
$13.02 - $21.3 $25,532 - $41,769
1,961 Added 8.54%
24,914 $378,000
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $34,248 - $96,438
5,127 Added 28.76%
22,953 $392,000
Q3 2023

Nov 13, 2023
SELL
$8.36 - $26.5 $175 - $556
-21 Reduced 0.12%
17,826 $149,000
Q2 2023

Aug 10, 2023
BUY
$15.48 - $35.0 $33,607 - $75,985
2,171 Added 13.85%
17,847 $443,000
Q1 2023

May 11, 2023
SELL
$10.23 - $19.34 $14,864 - $28,101
-1,453 Reduced 8.48%
15,676 $235,000
Q4 2022

Feb 02, 2023
BUY
$5.01 - $11.83 $12,239 - $28,900
2,443 Added 16.63%
17,129 $202,000
Q3 2022

Nov 04, 2022
SELL
$4.57 - $8.4 $1,265 - $2,326
-277 Reduced 1.85%
14,686 $87,000
Q2 2022

Aug 01, 2022
SELL
$3.74 - $10.66 $34,901 - $99,479
-9,332 Reduced 38.41%
14,963 $64,000
Q1 2022

May 10, 2022
SELL
$7.81 - $20.45 $31,255 - $81,840
-4,002 Reduced 14.14%
24,295 $231,000
Q4 2021

Feb 08, 2022
BUY
$15.2 - $35.51 $180,408 - $421,468
11,869 Added 72.25%
28,297 $537,000
Q3 2021

Nov 12, 2021
SELL
$21.78 - $40.45 $366,513 - $680,692
-16,828 Reduced 50.6%
16,428 $547,000
Q2 2021

Aug 13, 2021
BUY
$32.5 - $48.96 $23,107 - $34,810
711 Added 2.18%
33,256 $1.29 Million
Q1 2021

May 14, 2021
BUY
$41.61 - $54.3 $291,561 - $380,480
7,007 Added 27.44%
32,545 $1.57 Million
Q4 2020

Feb 09, 2021
BUY
$25.27 - $54.9 $301,344 - $654,682
11,925 Added 87.6%
25,538 $1.33 Million
Q3 2020

Nov 13, 2020
BUY
$18.49 - $27.24 $8,967 - $13,211
485 Added 3.69%
13,613 $364,000
Q2 2020

Aug 03, 2020
BUY
$8.9 - $21.84 $116,839 - $286,715
13,128 New
13,128 $256,000
Q1 2020

May 15, 2020
SELL
$7.14 - $15.99 $83,409 - $186,795
-11,682 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$5.1 - $11.2 $59,578 - $130,838
11,682 New
11,682 $130,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email